Form 4: INVO Fertility Director Sells, Surrenders Shares

INVO Fertility Director Matthew K Szot reported selling 4 shares and surrendering 3 shares of common stock, while holding adjusted stock options.

Summary

• Director Matthew K Szot of INVO Fertility, Inc. reported transactions in the company's common stock.
• On December 3, 2025, Szot sold 4 shares of common stock at a price of $1.52 per share.
• On December 4, 2025, Szot surrendered 3 shares of common stock to the issuer without receiving any payment or value in return.
• Following these transactions, Szot's direct beneficial ownership of common stock is 0 shares.
• Szot holds stock options to buy 5,646 shares of common stock at an exercise price of $8.08 per share.
• These stock options were adjusted for a 1-for-8 reverse stock split that occurred on November 28, 2025.
• The options vest in four equal installments beginning on the first day of the calendar quarter following August 26, 2025, and on the first day of each calendar quarter thereafter until fully vested, with an expiration date of August 26, 2035.

Sentiment

Score: 3

Explanation: The director's sale and surrender of common stock, reducing direct ownership to zero, could be interpreted negatively by the market, despite the continued holding of stock options.

Negatives

• Director Matthew K Szot sold 4 shares of common stock at $1.52 per share on December 3, 2025.
• Director Matthew K Szot surrendered 3 shares of common stock to the issuer without receiving any payment or value on December 4, 2025, reducing direct beneficial ownership to zero.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Director Matthew K Szot surrendered 3 shares of common stock to INVO Fertility, Inc. without receiving any payment or other value in return.

Stakeholder Impact

• Shareholders: The sale and surrender of shares by a director might be perceived as a lack of confidence, potentially influencing investor sentiment.

Next Steps

• Continued vesting of stock options in four equal installments beginning the first day of the calendar quarter following August 26, 2025.

Key Dates

Recommendation

The director's decision to sell a portion of their common stock and surrender the remaining direct holdings, effectively reducing their direct ownership to zero, sends a negative signal regarding their confidence in the immediate equity value. While stock options are still held, the direct divestment suggests a cautious stance, which could prompt investors to reconsider their position.

Keywords

INVO Fertility, IVF, Matthew K Szot, Form 4, Insider Trading, Stock Sale, Stock Option, Director Transaction, Reverse Split